Mucolytic
Pregnancy: Caution — avoid in first trimester
Carbocisteine (ENT — Mucolytic)
Brand names: Mucodyne
Adult dose
Dose: 750 mg TDS (with meals) initially, reduce to 375 mg TDS when mucus normalises
Route: Oral
Frequency: TDS
Max: 2250 mg/day
For chronic sinusitis, chronic otitis media with effusion (glue ear), and COPD with excessive mucus. Reduces sputum viscosity. Used to facilitate drainage in ENT conditions.
Paediatric dose
Route: Oral syrup
Frequency: BD–TDS
Max: 750 mg/day
Concentration: 125 mg/5 mL or 250 mg/5 mL mg/ml
Children 2–5 years: 62.5–125 mg TDS. Children 5–12 years: 250 mg TDS. Reduce to BD after improvement.
Dose adjustments
Renal
No dose adjustment required
Hepatic
Caution in severe hepatic impairment
Clinical pearls
- Otitis media with effusion (glue ear): mucolytics may help drain middle ear mucus in chronic OME; limited evidence but commonly prescribed in practice
- Chronic rhinosinusitis: adjunct to saline irrigation and intranasal steroids — mucolytic reduces mucus viscosity and improves sinonasal drainage
- Cochrane review: mucolytics reduce COPD exacerbation rates — also applies in recurrent sinusitis
Contraindications
- Active peptic ulcer disease
Side effects
- Nausea
- GI disturbance
- Rash (rare)
Interactions
- None significant
Monitoring
- Symptom improvement (mucus viscosity, drainage)
- GI symptoms
Reference: BNFc; BNF; ENT-UK Sinusitis Guidelines; Cochrane Review. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020